Cubist presents results from Phase 3 trials of ceftolozane/tazobactam
moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
[Business Wire] – Cubist Pharmaceuticals, Inc. today announced the first detailed results from positive pivotal Phase 3 clinical trials of its antibiotic candidate ceftolozane/tazobactam in development to treat serious infections including complicated ur moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
[Business Wire] – Cubist Pharmaceuticals, Inc. today announced it is voluntarily recalling one lot of CUBICIN® to the user level due to the presence of part moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
[Reuters] – A panel of advisers to the U.S. Food and Drug Administration gave favorable reviews on Monday to two new medications to treat acute bacterial skin infections. The panel voted unanimously that Cubist Pharmaceuticals Inc’s tedizolid and Durata moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is […]
[at The Wall Street Journal] – Apple and Samsung are squaring off this week in a new round of their long-running patent feud. This time, however, the docket might as well read Apple v. Google moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to […]
[at The Wall Street Journal] – Telecom providers want to end the era of copper-wire landlines. moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]
moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]